Why would Am­gen want to buy Alex­ion? An­a­lysts call hot­ly ru­mored takeover un­like­ly, but seize the mo­ment

A ru­mor that Am­gen is clos­ing in on buy­out deal for Alex­ion has sparked a guess­ing game on just what kind of M&A strat­e­gy Am­gen is pur­su­ing and how much Alex­ion is worth.

Mizuho an­a­lyst Sal­im Syed first lent cre­dence to the re­port out of the Span­ish news out­let In­tere­conomía, which said Am­gen is bid­ding as much as $200 per share. While the source may be ques­tion­able, “the con­cept of this hap­pen­ing doesn’t sound too crazy to me,” he wrote.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.